🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where communities with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Material Elimination

According to TikTok, the service has taken down problematic material and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at residence.

After minutes of joining one community, a seller shared WhatsApp details, where most transactions take place. The vendor sent an guidebook and promised delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages display dark colored packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind retatrutide is sound, these online versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already seen individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may expose users to possibly serious medical dangers”.